Overview

NSAID vs Steroid in Trabeculectomy Wound Management

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the efficacy of steroid vs NSAID treatment in relation to trabeculectomy wound management. Eligible study participants will be randomized to receive either steroid or NSAID topical treatment one week post-trabeculectomy. Each group will dose with their assigned study treatment until three months post-trabeculectomy. Study participants will be followed for twelve months post-trabeculectomy.
Phase:
Phase 4
Details
Lead Sponsor:
Cindy Hutnik
Collaborator:
Glaucoma Research Society of Canada
Treatments:
BB 1101
Bromfenac
Dexamethasone
Dexamethasone acetate
Nepafenac